Decoy Therapeutics Inc. Accounts Payable
Decoy Therapeutics Inc. (DCOY) had Accounts Payable of $1.33 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $1.33M.
- 2026-03-31: Accounts Payable, Current $936.03K.
- 2025-12-31: Accounts Payable, Current $940.59K.
- 2025-09-30: Accounts Payable, Current $1.10M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.33M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $936.03K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $940.59K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.48M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.47M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $936.99K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $165.80K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $643.05K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $713.96K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $602.85K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $1.09M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.29M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.51M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.86M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $1.72M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.87M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $1.69M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.54M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $1.23M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.28M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.57M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $1.85M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $1.20M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.15M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $979.82K 10-Q/A · filed 2020-05-15 | |
| 2019-12-31 | $1.79M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $1.64M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $805.52K 10-Q · filed 2019-07-17 | |
| 2019-03-31 | $186.35K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $379.78K 10-K · filed 2020-03-23 | $342.53K 10-K · filed 2019-03-06 |
| 2018-09-30 | $1.28M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $1.15M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $2.24M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $2.00M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $919.03K 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $1.81M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $818.79K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $1.19M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $1.26M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $1.54M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $1.54M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $875.65K 10-K · filed 2017-03-08 | |
| 2015-09-30 | $692.68K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $812.32K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $567.89K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $578.65K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |